All Access Articles |
- Ligand Pharmaceuticals Reports Strong Revenue Growth | 2026-02-26 | UNITED STATES
- Ligand Pharmaceuticals Prices $400M Convertible Notes | 2025-08-15 | PHARMACEUTICAL
- Ligand Pharmaceuticals Offers $400M Convertible Notes | 2025-08-11 | PHARMACEUTICAL
- Ligand Pharmaceuticals Acquires Apeiron Biologics AG for $100M | 2024-07-08 | PHARMACEUTICAL